Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 252

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 252
---
% of the average of our total assets at year-end for the last two completed fiscal years; and |

| • |     | any of our directors (including director nominees), executive officers, or beneficial holders of more than 5% of                                                                                            
 any class of our voting securities, or any immediate family member of, or person sharing the household with, any of these individuals or entities, had or will have a direct or indirect material interest. |

PIPE Financing and Subscription Agreement On December 19, 2024, we entered into the Subscription Agreement with each of the PIPE Investors, pursuant to which we agreed to sell to the PIPE Investors (i) 21,592,000 shares of our common stock, par, at a purchase price of $2.40 per share, and (ii) 20,076,500 Pre-Funded Warrants to acquire common stock, at a purchase price of $2.3999 per Pre-FundedWarrant, for an aggregate purchase price of $100 million (collectively, the “PIPE Financing”). The Pre-FundedWarrants will have an exercise price of $0.0001 per share of common stock, be immediately exercisable, and remain exercisable until exercised in full. The holders of Pre-FundedWarrants may not exercise a Pre-FundedWarrant if the holder, together with its affiliates, would beneficially own more than 4.99% or 9.99%, at the election of the holder, of the number of shares of common stock outstanding immediately after giving effect to such exercise. The holders of Pre-FundedWarrants may increase or decrease such percentages not in excess of 19.99% by providing at least 61 days’ prior notice to us. The closing of the PIPE Financing is expected to occur on a date that is no later than five business days from the date on which stockholder approval is obtained. Registration Rights Agreement At the closing of the PIPE Financing, in connection with the Subscription Agreement, we intend to enter into a Registration Rights Agreement with the PIPE Investors. Pursuant to the Registration Rights Agreement, we will prepare and file a resale registration statement with the SEC on or prior to the later of (i) thirty (30) days following the closing of the PIPE Financing and (ii) five (5) business days following the filing of our audited financial statements for the year ended December 31, 2024. We will use its commercially reasonable efforts to cause this registration statement to be declared effective by the SEC within 60 calendar